NDC product
PIOGLITAZONE HYDROCHLORIDE
NDC 84677-027 · GSMS, Incorporated
Key facts
| Product NDC | 84677-027 |
|---|---|
| Proprietary name | PIOGLITAZONE HYDROCHLORIDE |
| Nonproprietary name | PIOGLITAZONE HYDROCHLORIDE |
| Substances | PIOGLITAZONE HYDROCHLORIDE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | GSMS, Incorporated |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA210165 |
| Pharmacologic classes | Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS] |
| Marketing start | Jun 20, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: